Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Autologous alpha-DC1/TBVA vaccine |
| Synonyms | |
| Therapy Description |
Autologous alpha-DC1/TBVA vaccine is comprised of patient-derived dendritic cells loaded with tumor blood vessel antigen (TBVA)-derived peptides, which may lead to increased antitumor immune response (PMID: 34782430). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Autologous alpha-DC1/TBVA vaccine | Autologous alpha-DC1/TBVA vaccine is comprised of patient-derived dendritic cells loaded with tumor blood vessel antigen (TBVA)-derived peptides, which may lead to increased antitumor immune response (PMID: 34782430). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|